These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 33506371)

  • 41. Silent progression in patients with rheumatoid arthritis: is DAS28 remission an insufficient goal in RA? Results from the German Remission-plus cohort.
    Sewerin P; Vordenbaeumen S; Hoyer A; Brinks R; Buchbender C; Miese F; Schleich C; Klein S; Schneider M; Ostendorf B
    BMC Musculoskelet Disord; 2017 Apr; 18(1):163. PubMed ID: 28420375
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate.
    Wells G; Becker JC; Teng J; Dougados M; Schiff M; Smolen J; Aletaha D; van Riel PL
    Ann Rheum Dis; 2009 Jun; 68(6):954-60. PubMed ID: 18490431
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pain persists in DAS28 rheumatoid arthritis remission but not in ACR/EULAR remission: a longitudinal observational study.
    Lee YC; Cui J; Lu B; Frits ML; Iannaccone CK; Shadick NA; Weinblatt ME; Solomon DH
    Arthritis Res Ther; 2011 Jun; 13(3):R83. PubMed ID: 21651807
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An evaluation of molecular and clinical remission in rheumatoid arthritis by assessing radiographic progression.
    van der Helm-van Mil AH; Knevel R; Cavet G; Huizinga TW; Haney DJ
    Rheumatology (Oxford); 2013 May; 52(5):839-46. PubMed ID: 23287359
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treat-to-target strategies aiming at additional ultrasound remission is associated with better control of disease activity and less flare in rheumatoid arthritis.
    Geng Y; Wang L; Zhang X; Ji L; Deng X; Zhang Z
    Clin Rheumatol; 2021 Jan; 40(1):113-121. PubMed ID: 32514681
    [TBL] [Abstract][Full Text] [Related]  

  • 46. How much does Disease Activity Score in 28 joints ESR and CRP calculations underestimate disease activity compared with the Simplified Disease Activity Index?
    Fleischmann R; van der Heijde D; Koenig AS; Pedersen R; Szumski A; Marshall L; Bananis E
    Ann Rheum Dis; 2015 Jun; 74(6):1132-7. PubMed ID: 25143522
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of rheumatoid arthritis composite disease activity indices and residual activity in a Brazilian multicenter study- REAL study.
    Santos IA; Donizeti Ribeiro de Oliveira R; Couto Luna Almeida S; Vargas-Santos AB; Balbino Chaves Amorim R; Monteiro Gomides AP; de Albuquerque CP; Barros Bertolo M; Brandão Resende Guimarães MF; da Costa Pinto MR; Gomes Resende G; Dalva Neubarth Giorgi R; de Carvalho Saciloto N; Radominski SC; Borghi FM; Rossi Bonfiglioli K; Carrico da Silva H; de Fatima L da Cunha Sauma M; Alves Pereira I; Werner de Castro GR; Viegas Brenol C; Machado Xavier R; Maria Henrique Mota L; Louzada-Junior P; da Rocha Castelar-Pinheiro G
    PLoS One; 2022; 17(9):e0273789. PubMed ID: 36174077
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Remission in rheumatoid arthritis: a comparison of the 2 newly proposed ACR/EULAR remission criteria with the rheumatoid arthritis disease activity index-5, a patient self-report disease activity index.
    Rintelen B; Sautner J; Haindl P; Mai H; Brezinschek HP; Leeb BF
    J Rheumatol; 2013 Apr; 40(4):394-400. PubMed ID: 23378466
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differing local and systemic inflammatory burden in polyarticular psoriatic arthritis and rheumatoid arthritis patients on anti-TNF treatment in clinical remission.
    Ramírez J; Inciarte-Mundo J; Cuervo A; Ruiz-Esquide V; Hernández MV; Sanmartí R; Cañete JD
    Clin Exp Rheumatol; 2017; 35(1):74-79. PubMed ID: 27749227
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Discontinuation of adalimumab after attaining disease activity score 28-erythrocyte sedimentation rate remission in patients with rheumatoid arthritis (HONOR study): an observational study.
    Hirata S; Saito K; Kubo S; Fukuyo S; Mizuno Y; Iwata S; Nawata M; Sawamukai N; Nakano K; Yamaoka K; Tanaka Y
    Arthritis Res Ther; 2013 Sep; 15(5):R135. PubMed ID: 24286472
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevalence of sustained remission in rheumatoid arthritis: impact of criteria sets and disease duration, a Nationwide Study in Sweden.
    Einarsson JT; Willim M; Ernestam S; Saxne T; Geborek P; Kapetanovic MC
    Rheumatology (Oxford); 2019 Feb; 58(2):227-236. PubMed ID: 29538755
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sustained clinical remission of rheumatoid arthritis and its predictive factors in an unselected adult Chinese population from 2009 to 2018.
    Xie W; Li J; Zhang X; Sun X; Zhang Z
    Int J Rheum Dis; 2019 Sep; 22(9):1670-1678. PubMed ID: 31297977
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Persistence of ultrasound synovitis in patients with rheumatoid arthritis fulfilling the DAS28 and/or the new ACR/EULAR RA remission definitions: results of an observational cohort study.
    Zufferey P; Möller B; Brulhart L; Tamborrini G; Scherer A; Finckh A; Ziswiler HR
    Joint Bone Spine; 2014 Oct; 81(5):426-32. PubMed ID: 24956986
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Biomarkers in Remission According to Different Criteria in Patients with Rheumatoid Arthritis.
    Yilmaz-Oner S; Ozen G; Can M; Atagunduz P; Direskeneli H; Inanc N
    J Rheumatol; 2015 Nov; 42(11):2066-70. PubMed ID: 26472417
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Remission assessment of rheumatoid arthritis in daily practice in China: a cross-sectional observational study.
    Zhu H; Li R; Da Z; Bi L; Li X; Li Y; Liu C; Zhang F; Li Z; Liu X; Zhang Z; Sun L; Wang Y; Zhang W; Jiang Q; Chen J; Chen Q; Li Z; Wu L; Qi W; Xu J; Cui X; Wang X; Li L; Leng X; Wang G; Zhao D; Jiang L; He D; Liu X; Li L; Fang Y; Huang C; Wu H; Hu S; Li Q; Song H; Xiao W; Gong L; Zhang L; Li X; Li Z; Su Y
    Clin Rheumatol; 2018 Mar; 37(3):597-605. PubMed ID: 29116543
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The DAS28-ESR cutoff value necessary to achieve remission under the new Boolean-based remission criteria in patients receiving tocilizumab.
    Hirabayashi Y; Ishii T;
    Clin Rheumatol; 2013 Jan; 32(1):123-7. PubMed ID: 23090655
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of Magnetic Resonance Imaging vs Conventional Treat-to-Target Strategies on Disease Activity Remission and Radiographic Progression in Rheumatoid Arthritis: The IMAGINE-RA Randomized Clinical Trial.
    Møller-Bisgaard S; Hørslev-Petersen K; Ejbjerg B; Hetland ML; Ørnbjerg LM; Glinatsi D; Møller J; Boesen M; Christensen R; Stengaard-Pedersen K; Madsen OR; Jensen B; Villadsen JA; Hauge EM; Bennett P; Hendricks O; Asmussen K; Kowalski M; Lindegaard H; Nielsen SM; Bliddal H; Krogh NS; Ellingsen T; Nielsen AH; Balding L; Jurik AG; Thomsen HS; Østergaard M
    JAMA; 2019 Feb; 321(5):461-472. PubMed ID: 30721294
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Predictors and the optimal duration of sustained remission in rheumatoid arthritis.
    Yilmaz-Oner S; Gazel U; Can M; Atagunduz P; Direskeneli H; Inanc N
    Clin Rheumatol; 2019 Nov; 38(11):3033-3039. PubMed ID: 31270696
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Routine Assessment of Patient Index Data 3 and the American College of Rheumatology/European League Against Rheumatism Provisional Remission Definitions as Predictors of Radiographic Outcome in a Rheumatoid Arthritis Clinical Trial With Tocilizumab.
    Khawaja MN; Bergman MJ; Yourish J; Pei J; Reiss W; Keystone E
    Arthritis Care Res (Hoboken); 2017 May; 69(5):609-615. PubMed ID: 27564431
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Can remission in rheumatoid arthritis be assessed without laboratory tests or a formal joint count? possible remission criteria based on a self-report RAPID3 score and careful joint examination in the ESPOIR cohort.
    Castrejón I; Dougados M; Combe B; Guillemin F; Fautrel B; Pincus T
    J Rheumatol; 2013 Apr; 40(4):386-93. PubMed ID: 23378463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.